Skip to content

Investigation of the effect of erector spinae plane block, a new pain-relieving method for the relief of post-operative pain in patients whose part of the liver will be removed.

Investigation of the Effect of Ultrasonography Guided Bilateral Erector Spina Plane Block on Postoperative Opioid Consumption and Pain Scores in Patients with Hepatectomy Operation: A Prospective, Randomized, Controlled Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000466943
Enrollment
50
Registered
2020-04-09
Start date
2020-05-01
Completion date
2020-11-30
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The planned study will investigate the effectiveness of erector spina plane block, which is a newly defined and easily applicable plane block in abdominal surgery of this size whether it can reduce morphine consumption.

Interventions

ESP Block Application:All blocks will be performed by an anesthesiologist experienced in the block approximately 30 minutes before anesthesia induction. The block will be made at the level of the T8 vertebra. The T7 vertebra that corresponds to the level of the lower ends of the scapula will be identified and the T8 vertebra below one level will be detected by palpation. Patients will be laid in prone position and skin preparation will be done with 10% povidone iodine. Skin-subcutaneous anesthes

ESP Block Application:All blocks will be performed by an anesthesiologist experienced in the block approximately 30 minutes before anesthesia induction. The block will be made at the level of the T8 vertebra. The T7 vertebra that corresponds to the level of the lower ends of the scapula will be identified and the T8 vertebra below one level will be detected by palpation. Patients will be laid in prone position and skin preparation will be done with 10% povidone iodine. Skin-subcutaneous anesthesia will be provided with 3 ml 2% lidocaine at the target injection site. T8 spinous process in the midline and horizontal plane will be displayed first by using a linear probe coated with a sterile drape at 8 mHz frequency accompanied by ultrasonography. The probe is then turned to the longitudinal plane, approximately 3 cm from the midline, the transverse process on the left lateral and the erector spina muscle will be displayed on it. The 22-gauge, 80-mm block needle will be advanced cranio-caudal as in-plane and the transverse process will be touched. Then, after the needle is minimally retracted, 20 ml 0.375% bupivacaine hydrochloride + 4 mg dexamethasone will be injected, and simultaneous local anesthetic emission will be monitored by ultrasonography. By applying the same procedure to the right side, bilateral ESP block will be performed. Loss of sensation of warm-cold sensation below and above the bilateral T8 dermatome level 20 minutes after the block is made will be considered as block success. Participants in this group will also receive PCA postoperatively.

Sponsors

Necmettin Erbakan University Scientific Research Project Coordinator
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Patients with ASA physical status I-III, who will undergo elective hepatectomy surgery, bilateral subcostal incision as surgical incision, and self-retaining retractor will be used in surgery will be included.

Exclusion criteria

Obese (body mass index> 30 kg / m2), local skin infection in the area where the needle will be inserted, known allergy to any of the drugs to be used in the study, coagulopathy, chronic opioid consumption, disability to use PCA device, patients with advanced hepatic insufficiency, advanced renal insufficiency and refusal to participate in the study will be excluded.

Outcome results

None listed

Source: ANZCTR · Data processed: Aug 9, 2026